Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation
Public ClinicalTrials.gov record NCT03850509. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Proof-of-Concept Trial to Assess the Efficacy and Safety of Orally Administered OPS-2071 for 12 Weeks in Subjects With Crohn's Disease Showing Symptoms of Active Inflammation Despite Ongoing Treatment
Study identification
- NCT ID
- NCT03850509
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Industry
- Enrollment
- 3 participants
Conditions and interventions
Conditions
Interventions
- OPS-2071 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 24, 2020
- Primary completion
- May 21, 2020
- Completion
- May 21, 2020
- Last update posted
- Jun 14, 2021
2020
United States locations
- U.S. sites
- 24
- U.S. states
- 12
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| United States, California | Los Angeles | California | 90067 | — |
| United States, California | San Carlos | California | 94070 | — |
| United States, Colorado | Colorado Springs | Colorado | 80907 | — |
| United States, Florida | Clearwater | Florida | 33756 | — |
| United States, Florida | Hialeah | Florida | 33012 | — |
| United States, Florida | Kissimmee | Florida | 34759 | — |
| United States, Florida | Naples | Florida | 34102 | — |
| United States, Florida | Orlando | Florida | 32825 | — |
| United States, Florida | Plantation | Florida | 33322 | — |
| United States, Georgia | Decatur | Georgia | 30033 | — |
| United States, Georgia | Doraville | Georgia | 30362 | — |
| United States, Kansas | Shawnee Mission | Kansas | 66226 | — |
| United States, Maryland | Chevy Chase | Maryland | 20815 | — |
| United States, North Carolina | Greenville | North Carolina | 27834 | — |
| United States, Ohio | Cincinnati | Ohio | 45219 | — |
| United States, Ohio | Dayton | Ohio | 45417 | — |
| United States, Oklahoma | Oklahoma City | Oklahoma | 73112 | — |
| United States, South Carolina | Rock Hill | South Carolina | 29732 | — |
| United States, Texas | Austin | Texas | 78704 | — |
| United States, Texas | Harlingen | Texas | 78550 | — |
| United States, Texas | San Antonio | Texas | 78229 | — |
| United States, Texas | Sugar Land | Texas | 77479 | — |
| United States, Texas | Tyler | Texas | 75701 | — |
| United States, Virginia | Lynchburg | Virginia | 24502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03850509, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 14, 2021 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03850509 live on ClinicalTrials.gov.